Wolverine Asset Management LLC Invitae Corp Call Options Transaction History

Wolverine Asset Management LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 04, 2022	SELL	$6.28 - $15.59 $38,308 - $95,099	-6,100 Reduced 71.76%	2,400 $19,000
Q3 2021 Nov 12, 2021	SELL	$24.31 - $33.6 $4,862 - $6,720	-200 Reduced 2.3%	8,500 $241,000
Q2 2021 Aug 13, 2021	SELL	$26.09 - $40.4 $75,661 - $117,160	-2,900 Reduced 25.0%	8,700 $293,000
Q1 2021 May 13, 2021	SELL	$33.06 - $56.93 $62,814 - $108,167	-1,900 Reduced 14.07%	11,600 $443,000
Q4 2020 Feb 12, 2021	BUY	$39.09 - $57.4 $277,539 - $407,540	7,100 Added 110.94%	13,500 $564,000
Q2 2020 Aug 13, 2020	SELL	$11.71 - $30.29 $536,318 - $1.39 Million	-45,800 Reduced 87.74%	6,400 $193,000
Q1 2020 May 13, 2020	SELL	$7.64 - $27.5 $59,592 - $214,500	-7,800 Reduced 13.0%	52,200 $713,000
Q3 2019 Nov 14, 2019	BUY	$18.85 - $27.5 $1.13 Million - $1.65 Million	60,000 New	60,000 $1.16 Million

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.